Home›Breast Cancer›Hope Rugo, MD, on the Accelerated Approval of Sacituzumab Govitecan-hziy

Hope Rugo, MD, on the Accelerated Approval of Sacituzumab Govitecan-hziy

January 15, 2022

139

The breast cancer expert discussed the implications of this approval, as well as the data that led to the approval of sacituzumab govitecan-hziy.

Fitcoachion

Problem solver. Creator. Thinker. Web nerd. Food enthusiast. Pop culture junkie. Snowboarder, dreamer, hiphop head, hand letterer and growthhacker. Producing at the crossroads of modernism and programing to express ideas through design. I am 20 years old.